Global Non-Steroidal Anti-Inflammatory API Market Research Report 2024

Report ID: 1894125 | Published Date: Oct 2024 | No. of Page: 96 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
1 Non-Steroidal Anti-Inflammatory API Market Overview
    1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory API
    1.2 Non-Steroidal Anti-Inflammatory API Segment by Type
        1.2.1 Global Non-Steroidal Anti-Inflammatory API Market Size Growth Rate Analysis by Type 2022 VS 2028
        1.2.2 Aspirin
        1.2.3 Ibuprofen
        1.2.4 Naproxen
        1.2.5 Diclofenac
        1.2.6 Oxapzin
        1.2.7 Others
    1.3 Non-Steroidal Anti-Inflammatory API Segment by Application
        1.3.1 Global Non-Steroidal Anti-Inflammatory API Consumption Comparison by Application: 2022 VS 2028
        1.3.2 Medical Pharmaceutical
        1.3.3 Scientific Research
    1.4 Global Market Growth Prospects
        1.4.1 Global Non-Steroidal Anti-Inflammatory API Revenue Estimates and Forecasts (2017-2028)
        1.4.2 Global Non-Steroidal Anti-Inflammatory API Production Capacity Estimates and Forecasts (2017-2028)
        1.4.3 Global Non-Steroidal Anti-Inflammatory API Production Estimates and Forecasts (2017-2028)
    1.5 Global Market Size by Region
        1.5.1 Global Non-Steroidal Anti-Inflammatory API Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
        1.5.2 North America Non-Steroidal Anti-Inflammatory API Estimates and Forecasts (2017-2028)
        1.5.3 Europe Non-Steroidal Anti-Inflammatory API Estimates and Forecasts (2017-2028)
        1.5.4 China Non-Steroidal Anti-Inflammatory API Estimates and Forecasts (2017-2028)
        1.5.5 Japan Non-Steroidal Anti-Inflammatory API Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
    2.1 Global Non-Steroidal Anti-Inflammatory API Production Capacity Market Share by Manufacturers (2017-2022)
    2.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Manufacturers (2017-2022)
    2.3 Non-Steroidal Anti-Inflammatory API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.4 Global Non-Steroidal Anti-Inflammatory API Average Price by Manufacturers (2017-2022)
    2.5 Manufacturers Non-Steroidal Anti-Inflammatory API Production Sites, Area Served, Product Types
    2.6 Non-Steroidal Anti-Inflammatory API Market Competitive Situation and Trends
        2.6.1 Non-Steroidal Anti-Inflammatory API Market Concentration Rate
        2.6.2 Global 5 and 10 Largest Non-Steroidal Anti-Inflammatory API Players Market Share by Revenue
        2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
    3.1 Global Production Capacity of Non-Steroidal Anti-Inflammatory API Market Share by Region (2017-2022)
    3.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Region (2017-2022)
    3.3 Global Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.4 North America Non-Steroidal Anti-Inflammatory API Production
        3.4.1 North America Non-Steroidal Anti-Inflammatory API Production Growth Rate (2017-2022)
        3.4.2 North America Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.5 Europe Non-Steroidal Anti-Inflammatory API Production
        3.5.1 Europe Non-Steroidal Anti-Inflammatory API Production Growth Rate (2017-2022)
        3.5.2 Europe Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.6 China Non-Steroidal Anti-Inflammatory API Production
        3.6.1 China Non-Steroidal Anti-Inflammatory API Production Growth Rate (2017-2022)
        3.6.2 China Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.7 Japan Non-Steroidal Anti-Inflammatory API Production
        3.7.1 Japan Non-Steroidal Anti-Inflammatory API Production Growth Rate (2017-2022)
        3.7.2 Japan Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Non-Steroidal Anti-Inflammatory API Consumption by Region
    4.1 Global Non-Steroidal Anti-Inflammatory API Consumption by Region
        4.1.1 Global Non-Steroidal Anti-Inflammatory API Consumption by Region
        4.1.2 Global Non-Steroidal Anti-Inflammatory API Consumption Market Share by Region
    4.2 North America
        4.2.1 North America Non-Steroidal Anti-Inflammatory API Consumption by Country
        4.2.2 United States
        4.2.3 Canada
    4.3 Europe
        4.3.1 Europe Non-Steroidal Anti-Inflammatory API Consumption by Country
        4.3.2 Germany
        4.3.3 France
        4.3.4 U.K.
        4.3.5 Italy
        4.3.6 Russia
    4.4 Asia Pacific
        4.4.1 Asia Pacific Non-Steroidal Anti-Inflammatory API Consumption by Region
        4.4.2 China
        4.4.3 Japan
        4.4.4 South Korea
        4.4.5 China Taiwan
        4.4.6 Southeast Asia
        4.4.7 India
        4.4.8 Australia
    4.5 Latin America
        4.5.1 Latin America Non-Steroidal Anti-Inflammatory API Consumption by Country
        4.5.2 Mexico
        4.5.3 Brazil
5 Segment by Type
    5.1 Global Non-Steroidal Anti-Inflammatory API Production Market Share by Type (2017-2022)
    5.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2022)
    5.3 Global Non-Steroidal Anti-Inflammatory API Price by Type (2017-2022)
6 Segment by Application
    6.1 Global Non-Steroidal Anti-Inflammatory API Production Market Share by Application (2017-2022)
    6.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application (2017-2022)
    6.3 Global Non-Steroidal Anti-Inflammatory API Price by Application (2017-2022)
7 Key Companies Profiled
    7.1 Luan Pharmaceutical
        7.1.1 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
        7.1.2 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.1.3 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.1.4 Luan Pharmaceutical Main Business and Markets Served
        7.1.5 Luan Pharmaceutical Recent Developments/Updates
    7.2 Basf Company
        7.2.1 Basf Company Non-Steroidal Anti-Inflammatory API Corporation Information
        7.2.2 Basf Company Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.2.3 Basf Company Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.2.4 Basf Company Main Business and Markets Served
        7.2.5 Basf Company Recent Developments/Updates
    7.3 Fengyuan Pharmaceutical
        7.3.1 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
        7.3.2 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.3.3 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.3.4 Fengyuan Pharmaceutical Main Business and Markets Served
        7.3.5 Fengyuan Pharmaceutical Recent Developments/Updates
    7.4 Xinhua Pharmaceutical
        7.4.1 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
        7.4.2 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.4.3 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.4.4 Xinhua Pharmaceutical Main Business and Markets Served
        7.4.5 Xinhua Pharmaceutical Recent Developments/Updates
    7.5 Changshu Huagang Pharmaceutical
        7.5.1 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
        7.5.2 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.5.3 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.5.4 Changshu Huagang Pharmaceutical Main Business and Markets Served
        7.5.5 Changshu Huagang Pharmaceutical Recent Developments/Updates
    7.6 Hebei Jiheng Group
        7.6.1 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Corporation Information
        7.6.2 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.6.3 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.6.4 Hebei Jiheng Group Main Business and Markets Served
        7.6.5 Hebei Jiheng Group Recent Developments/Updates
    7.7 Zhejiang Kangle Group
        7.7.1 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Corporation Information
        7.7.2 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.7.3 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.7.4 Zhejiang Kangle Group Main Business and Markets Served
        7.7.5 Zhejiang Kangle Group Recent Developments/Updates
    7.8 Hebei Jingye Medical Technology
        7.8.1 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Corporation Information
        7.8.2 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.8.3 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.8.4 Hebei Jingye Medical Technology Main Business and Markets Served
        7.7.5 Hebei Jingye Medical Technology Recent Developments/Updates
    7.9 Hunan Middle-south Pharmaceutical
        7.9.1 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
        7.9.2 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.9.3 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.9.4 Hunan Middle-south Pharmaceutical Main Business and Markets Served
        7.9.5 Hunan Middle-south Pharmaceutical Recent Developments/Updates
    7.10 Mallinckrodt Pharmaceuticals
        7.10.1 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Corporation Information
        7.10.2 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.10.3 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.10.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
        7.10.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
    7.11 IOL
        7.11.1 IOL Non-Steroidal Anti-Inflammatory API Corporation Information
        7.11.2 IOL Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.11.3 IOL Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.11.4 IOL Main Business and Markets Served
        7.11.5 IOL Recent Developments/Updates
    7.12 Novacyl
        7.12.1 Novacyl Non-Steroidal Anti-Inflammatory API Corporation Information
        7.12.2 Novacyl Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.12.3 Novacyl Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.12.4 Novacyl Main Business and Markets Served
        7.12.5 Novacyl Recent Developments/Updates
    7.13 Granules India Limited
        7.13.1 Granules India Limited Non-Steroidal Anti-Inflammatory API Corporation Information
        7.13.2 Granules India Limited Non-Steroidal Anti-Inflammatory API Product Portfolio
        7.13.3 Granules India Limited Non-Steroidal Anti-Inflammatory API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.13.4 Granules India Limited Main Business and Markets Served
        7.13.5 Granules India Limited Recent Developments/Updates
8 Non-Steroidal Anti-Inflammatory API Manufacturing Cost Analysis
    8.1 Non-Steroidal Anti-Inflammatory API Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API
    8.4 Non-Steroidal Anti-Inflammatory API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Non-Steroidal Anti-Inflammatory API Distributors List
    9.3 Non-Steroidal Anti-Inflammatory API Customers
10 Market Dynamics
    10.1 Non-Steroidal Anti-Inflammatory API Industry Trends
    10.2 Non-Steroidal Anti-Inflammatory API Market Drivers
    10.3 Non-Steroidal Anti-Inflammatory API Market Challenges
    10.4 Non-Steroidal Anti-Inflammatory API Market Restraints
11 Production and Supply Forecast
    11.1 Global Forecasted Production of Non-Steroidal Anti-Inflammatory API by Region (2023-2028)
    11.2 North America Non-Steroidal Anti-Inflammatory API Production, Revenue Forecast (2023-2028)
    11.3 Europe Non-Steroidal Anti-Inflammatory API Production, Revenue Forecast (2023-2028)
    11.4 China Non-Steroidal Anti-Inflammatory API Production, Revenue Forecast (2023-2028)
    11.5 Japan Non-Steroidal Anti-Inflammatory API Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
    12.1 Global Forecasted Demand Analysis of Non-Steroidal Anti-Inflammatory API
    12.2 North America Forecasted Consumption of Non-Steroidal Anti-Inflammatory API by Country
    12.3 Europe Market Forecasted Consumption of Non-Steroidal Anti-Inflammatory API by Country
    12.4 Asia Pacific Market Forecasted Consumption of Non-Steroidal Anti-Inflammatory API by Region
    12.5 Latin America Forecasted Consumption of Non-Steroidal Anti-Inflammatory API by Country
13 Forecast by Type and by Application (2023-2028)
    13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
        13.1.1 Global Forecasted Production of Non-Steroidal Anti-Inflammatory API by Type (2023-2028)
        13.1.2 Global Forecasted Revenue of Non-Steroidal Anti-Inflammatory API by Type (2023-2028)
        13.1.3 Global Forecasted Price of Non-Steroidal Anti-Inflammatory API by Type (2023-2028)
    13.2 Global Forecasted Consumption of Non-Steroidal Anti-Inflammatory API by Application (2023-2028)
        13.2.1 Global Forecasted Production of Non-Steroidal Anti-Inflammatory API by Application (2023-2028)
        13.2.2 Global Forecasted Revenue of Non-Steroidal Anti-Inflammatory API by Application (2023-2028)
        13.2.3 Global Forecasted Price of Non-Steroidal Anti-Inflammatory API by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
    15.1 Methodology/Research Approach
        15.1.1 Research Programs/Design
        15.1.2 Market Size Estimation
        15.1.3 Market Breakdown and Data Triangulation
    15.2 Data Source
        15.2.1 Secondary Sources
        15.2.2 Primary Sources
    15.3 Author List
    15.4 Disclaimer
List of Tables
    Table 1. Global Non-Steroidal Anti-Inflammatory API Market Size by Type (Tons) & (US$ Million) (2022 VS 2028)
    Table 2. Global Non-Steroidal Anti-Inflammatory API Market Size by Application (Tons) & (US$ Million) (2022 VS 2028)
    Table 3. Non-Steroidal Anti-Inflammatory API Market Size Comparison by Region: 2017 VS 2021 VS 2028
    Table 4. Global Non-Steroidal Anti-Inflammatory API Production Capacity by Manufacturers (2017-2022) & (Tons)
    Table 5. Global Non-Steroidal Anti-Inflammatory API Production (Tons) by Manufacturers (2017-2022)
    Table 6. Global Non-Steroidal Anti-Inflammatory API Production Market Share by Manufacturers (2017-2022)
    Table 7. Global Non-Steroidal Anti-Inflammatory API Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 8. Global Non-Steroidal Anti-Inflammatory API Revenue Share by Manufacturers (2017-2022)
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory API as of 2021)
    Table 10. Global Market Non-Steroidal Anti-Inflammatory API Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 11. Manufacturers Non-Steroidal Anti-Inflammatory API Production Sites and Area Served
    Table 12. Manufacturers Non-Steroidal Anti-Inflammatory API Product Types
    Table 13. Global Non-Steroidal Anti-Inflammatory API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Non-Steroidal Anti-Inflammatory API Production Capacity (Tons) by Region (2017-2022)
    Table 16. Global Non-Steroidal Anti-Inflammatory API Production (Tons) by Region (2017-2022)
    Table 17. Global Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) by Region (2017-2022)
    Table 18. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Region (2017-2022)
    Table 19. Global Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 20. North America Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 21. Europe Non-Steroidal Anti-Inflammatory API Production (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 22. China Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 23. Japan Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 24. Global Non-Steroidal Anti-Inflammatory API Consumption Market by Region (2017-2022) & (Tons)
    Table 25. Global Non-Steroidal Anti-Inflammatory API Consumption Market Share by Region (2017-2022)
    Table 26. North America Non-Steroidal Anti-Inflammatory API Consumption by Country (2017-2022) & (Tons)
    Table 27. Europe Non-Steroidal Anti-Inflammatory API Consumption by Country (2017-2022) & (Tons)
    Table 28. Asia Pacific Non-Steroidal Anti-Inflammatory API Consumption by Region (2017-2022) & (Tons)
    Table 29. Latin America Non-Steroidal Anti-Inflammatory API Consumption by Country (2017-2022) & (Tons)
    Table 30. Global Non-Steroidal Anti-Inflammatory API Production (Tons) by Type (2017-2022)
    Table 31. Global Non-Steroidal Anti-Inflammatory API Production Market Share by Type (2017-2022)
    Table 32. Global Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) by Type (2017-2022)
    Table 33. Global Non-Steroidal Anti-Inflammatory API Revenue Share by Type (2017-2022)
    Table 34. Global Non-Steroidal Anti-Inflammatory API Price (US$/Kg) by Type (2017-2022)
    Table 35. Global Non-Steroidal Anti-Inflammatory API Production by Application (2017-2022) & (Tons)
    Table 36. Global Non-Steroidal Anti-Inflammatory API Production Market Share by Application (2017-2022)
    Table 37. Global Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) by Application (2017-2022)
    Table 38. Global Non-Steroidal Anti-Inflammatory API Revenue Share by Application (2017-2022)
    Table 39. Global Non-Steroidal Anti-Inflammatory API Price (US$/Kg) by Application (2017-2022)
    Table 40. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 41. Luan Pharmaceutical Specification and Application
    Table 42. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 43. Luan Pharmaceutical Main Business and Markets Served
    Table 44. Luan Pharmaceutical Recent Developments/Updates
    Table 45. Basf Company Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 46. Basf Company Specification and Application
    Table 47. Basf Company Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 48. Basf Company Main Business and Markets Served
    Table 49. Basf Company Recent Developments/Updates
    Table 50. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 51. Fengyuan Pharmaceutical Specification and Application
    Table 52. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 53. Fengyuan Pharmaceutical Main Business and Markets Served
    Table 54. Fengyuan Pharmaceutical Recent Developments/Updates
    Table 55. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 56. Xinhua Pharmaceutical Specification and Application
    Table 57. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 58. Xinhua Pharmaceutical Main Business and Markets Served
    Table 59. Xinhua Pharmaceutical Recent Developments/Updates
    Table 60. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 61. Changshu Huagang Pharmaceutical Specification and Application
    Table 62. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 63. Changshu Huagang Pharmaceutical Main Business and Markets Served
    Table 64. Changshu Huagang Pharmaceutical Recent Developments/Updates
    Table 65. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 66. Hebei Jiheng Group Specification and Application
    Table 67. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 68. Hebei Jiheng Group Main Business and Markets Served
    Table 69. Hebei Jiheng Group Recent Developments/Updates
    Table 70. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 71. Zhejiang Kangle Group Specification and Application
    Table 72. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 73. Zhejiang Kangle Group Main Business and Markets Served
    Table 74. Zhejiang Kangle Group Recent Developments/Updates
    Table 75. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 76. Hebei Jingye Medical Technology Specification and Application
    Table 77. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 78. Hebei Jingye Medical Technology Main Business and Markets Served
    Table 79. Hebei Jingye Medical Technology Recent Developments/Updates
    Table 80. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 81. Hunan Middle-south Pharmaceutical Specification and Application
    Table 82. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 83. Hunan Middle-south Pharmaceutical Main Business and Markets Served
    Table 84. Hunan Middle-south Pharmaceutical Recent Developments/Updates
    Table 85. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 86. Mallinckrodt Pharmaceuticals Specification and Application
    Table 87. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 88. Mallinckrodt Pharmaceuticals Main Business and Markets Served
    Table 89. Mallinckrodt Pharmaceuticals Recent Developments/Updates
    Table 90. IOL Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 91. IOL Specification and Application
    Table 92. IOL Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 93. IOL Main Business and Markets Served
    Table 94. IOL Recent Developments/Updates
    Table 95. Novacyl Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 96. Novacyl Specification and Application
    Table 97. Novacyl Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 98. Novacyl Main Business and Markets Served
    Table 99. Novacyl Recent Developments/Updates
    Table 100. Granules India Limited Non-Steroidal Anti-Inflammatory API Corporation Information
    Table 101. Granules India Limited Specification and Application
    Table 102. Granules India Limited Non-Steroidal Anti-Inflammatory API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 103. Granules India Limited Main Business and Markets Served
    Table 104. Granules India Limited Recent Developments/Updates
    Table 105. Production Base and Market Concentration Rate of Raw Material
    Table 106. Key Suppliers of Raw Materials
    Table 107. Non-Steroidal Anti-Inflammatory API Distributors List
    Table 108. Non-Steroidal Anti-Inflammatory API Customers List
    Table 109. Non-Steroidal Anti-Inflammatory API Market Trends
    Table 110. Non-Steroidal Anti-Inflammatory API Market Drivers
    Table 111. Non-Steroidal Anti-Inflammatory API Market Challenges
    Table 112. Non-Steroidal Anti-Inflammatory API Market Restraints
    Table 113. Global Non-Steroidal Anti-Inflammatory API Production (Tons) Forecast by Region (2023-2028)
    Table 114. North America Non-Steroidal Anti-Inflammatory API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 115. Europe Non-Steroidal Anti-Inflammatory API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 116. Asia Pacific Non-Steroidal Anti-Inflammatory API Consumption Forecast by Region (2023-2028) & (Tons)
    Table 117. Latin America Non-Steroidal Anti-Inflammatory API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 118. Global Non-Steroidal Anti-Inflammatory API Production Forecast by Type (2023-2028) & (Tons)
    Table 119. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 120. Global Non-Steroidal Anti-Inflammatory API Price Forecast by Type (2023-2028) & (US$/Kg)
    Table 121. Global Non-Steroidal Anti-Inflammatory API Production Forecast by Application (2023-2028) & (Tons)
    Table 122. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 123. Global Non-Steroidal Anti-Inflammatory API Price Forecast by Application (2023-2028) & (US$/Kg)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Non-Steroidal Anti-Inflammatory API
    Figure 2. Global Non-Steroidal Anti-Inflammatory API Market Share by Type: 2022 VS 2028
    Figure 3. Aspirin Product Picture
    Figure 4. Ibuprofen Product Picture
    Figure 5. Naproxen Product Picture
    Figure 6. Diclofenac Product Picture
    Figure 7. Oxapzin Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Non-Steroidal Anti-Inflammatory API Market Share by Application: 2022 VS 2028
    Figure 10. Medical Pharmaceutical
    Figure 11. Scientific Research
    Figure 12. Global Non-Steroidal Anti-Inflammatory API Revenue (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) (2017-2028)
    Figure 14. Global Non-Steroidal Anti-Inflammatory API Production Capacity (Tons) & (2017-2028)
    Figure 15. Global Non-Steroidal Anti-Inflammatory API Production (Tons) & (2017-2028)
    Figure 16. North America Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 17. Europe Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 18. China Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 19. Japan Non-Steroidal Anti-Inflammatory API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 20. Non-Steroidal Anti-Inflammatory API Production Share by Manufacturers in 2021
    Figure 21. Global Non-Steroidal Anti-Inflammatory API Revenue Share by Manufacturers in 2021
    Figure 22. Non-Steroidal Anti-Inflammatory API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 23. Global Market Non-Steroidal Anti-Inflammatory API Average Price (US$/Kg) of Key Manufacturers in 2021
    Figure 24. The Global 5 and 10 Largest Players: Market Share by Non-Steroidal Anti-Inflammatory API Revenue in 2021
    Figure 25. Global Non-Steroidal Anti-Inflammatory API Production Market Share by Region (2017-2022)
    Figure 26. North America Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate (2017-2022)
    Figure 27. Europe Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate (2017-2022)
    Figure 28. China Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate (2017-2022)
    Figure 29. Japan Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate (2017-2022)
    Figure 30. Global Non-Steroidal Anti-Inflammatory API Consumption Market Share by Region (2017-2022)
    Figure 31. North America Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 32. North America Non-Steroidal Anti-Inflammatory API Consumption Market Share by Country in 2021
    Figure 33. Canada Non-Steroidal Anti-Inflammatory API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 34. U.S. Non-Steroidal Anti-Inflammatory API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 35. Europe Non-Steroidal Anti-Inflammatory API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 36. Europe Non-Steroidal Anti-Inflammatory API Consumption Market Share by Country in 2021
    Figure 37. Germany Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 38. France Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 39. U.K. Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 40. Italy Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 41. Russia Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 42. Asia Pacific Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 43. Asia Pacific Non-Steroidal Anti-Inflammatory API Consumption Market Share by Regions in 2021
    Figure 44. China Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 45. Japan Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 46. South Korea Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 47. China Taiwan Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 49. India Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 50. Australia Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 51. Latin America Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 52. Latin America Non-Steroidal Anti-Inflammatory API Consumption Market Share by Country in 2021
    Figure 53. Mexico Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 54. Brazil Non-Steroidal Anti-Inflammatory API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 55. Production Market Share of Non-Steroidal Anti-Inflammatory API by Type (2017-2022)
    Figure 56. Production Market Share of Non-Steroidal Anti-Inflammatory API by Type in 2021
    Figure 57. Revenue Share of Non-Steroidal Anti-Inflammatory API by Type (2017-2022)
    Figure 58. Revenue Market Share of Non-Steroidal Anti-Inflammatory API by Type in 2021
    Figure 59. Production Market Share of Non-Steroidal Anti-Inflammatory API by Application (2017-2022)
    Figure 60. Production Market Share of Non-Steroidal Anti-Inflammatory API by Application in 2021
    Figure 61. Revenue Share of Non-Steroidal Anti-Inflammatory API by Application (2017-2022)
    Figure 62. Revenue Market Share of Non-Steroidal Anti-Inflammatory API by Application in 2021
    Figure 63. Manufacturing Cost Structure of Non-Steroidal Anti-Inflammatory API
    Figure 64. Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API
    Figure 65. Non-Steroidal Anti-Inflammatory API Industrial Chain Analysis
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
    Figure 68. Global Non-Steroidal Anti-Inflammatory API Production Market Share Forecast by Region (2023-2028)
    Figure 69. North America Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 70. Europe Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 71. China Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 72. Japan Non-Steroidal Anti-Inflammatory API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 73. Global Forecasted Demand Analysis of Non-Steroidal Anti-Inflammatory API (2017-2028) & (Tons)
    Figure 74. Global Non-Steroidal Anti-Inflammatory API Production Market Share Forecast by Type (2023-2028)
    Figure 75. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Type (2023-2028)
    Figure 76. Global Non-Steroidal Anti-Inflammatory API Production Market Share Forecast by Application (2023-2028)
    Figure 77. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Application (2023-2028)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Luan Pharmaceutical
Basf Company
Fengyuan Pharmaceutical
Xinhua Pharmaceutical
Changshu Huagang Pharmaceutical
Hebei Jiheng Group
Zhejiang Kangle Group
Hebei Jingye Medical Technology
Hunan Middle-south Pharmaceutical
Mallinckrodt Pharmaceuticals
IOL
Novacyl
Granules India Limited
Frequently Asked Questions
Non-Steroidal Anti-Inflammatory API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-Steroidal Anti-Inflammatory API report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-Steroidal Anti-Inflammatory API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports